Overview

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises:...

Open

$0.00

Prior close

$178.19

Today's high

$0.00

Today's low

$0.00

52 Week high

$188.73

52 Week low

$100.99

News

Business Wire • 8 days ago • RGEN

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS

Seeking Alpha • 9 days ago • RGEN

Repligen Corporation (RGEN) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Zacks Investment Research • 22 days ago • RGEN

Why Is Repligen (RGEN) Up 27.7% Since Last Earnings Report?

Zacks Investment Research • 23 days ago • RGEN

Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen

Zacks Investment Research • 23 days ago • RGEN

5 Biotech Stocks Worth Adding to Your Portfolio Now